News from northwest biotherapeutics, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( OTC-BB:NWBO)

Jan 25, 2016, 12:43 ET
Northwest Biotherapeutics Logo.

NW Bio Presenting At Phacilitate Immunotherapy World Forum

 Northwest Biotherapeutics, Inc. (NASDAQ: NWBO)("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies...

Jan 25, 2016, 09:30 ET
Northwest Biotherapeutics Logo

NW Bio Announces Appointment Of Two New Independent Directors With Biotech/Pharma Expertise and Cybersecurity/Investigations Expertise

 Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid...

Jan 08, 2016, 09:15 ET
Northwest Biotherapeutics Logo.

NW Bio Issues Statement on Adverse Market Conditions And NW Bio Stock Decline

Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for solid...

Dec 24, 2015, 16:29 ET
Northwest Biotherapeutics Logo.

NW Bio Announces Closing Of Registered Direct Offering of $12.6 Million

Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor...

Dec 23, 2015, 09:00 ET
Northwest Biotherapeutics Logo.

NW BIO ANNOUNCES A REGISTERED DIRECT OFFERING OF $12.6 MILLION

 Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid...

Dec 21, 2015, 13:05 ET
Northwest Biotherapeutics Logo.

NW Bio Announces Annual Meeting Results, Re-Election of Directors

 Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for...

Dec 08, 2015, 08:15 ET
Northwest Biotherapeutics Logo.

NW Bio Statement Regarding Appointments

 Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for...

Dec 08, 2015, 08:15 ET
Northwest Biotherapeutics Logo.

NW Bio Announces Establishment of Special Committee And Law Firm To Conduct Independent Investigation of Recent Allegations

 Northwest Biotherapeutics (NASDAQ: NWBO)("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for...

Nov 30, 2015, 07:15 ET
Northwest Biotherapeutics Logo.

NW Bio Plans to Expand Board, Welcomes Woodford's Call For Independent Investigation Of Allegations In Anonymous Internet Report

 Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for...

Oct 21, 2015, 12:00 ET
Northwest Biotherapeutics Logo.

NW Bio Has Entered Into An Agreement For $30 Million Of New Equity Funding From Woodford Investment Management

Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for solid...

Oct 19, 2015, 10:01 ET
Northwest Biotherapeutics Logo.

NW Bio Issues Statement on Highly Unusual Trading Activity

 Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for...

Sep 16, 2015, 09:20 ET
Northwest Biotherapeutics Logo

NW Bio Presenting New DCVax-Direct Poster At "The Inaugural International Cancer Immunotherapy Conference: Translating Science Into Survival" In New York City On Wednesday, September 16, 2015

 Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for...

Sep 14, 2015, 09:51 ET
Northwest Biotherapeutics Logo

NW to Present at 4th Annual SMi Cancer Vaccines Conference in London On Wednesday, September 16, 2015

Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for solid...

Aug 21, 2015, 15:22 ET
Northwest Biotherapeutics Logo.

NW Bio Confirms Phase III Trial of DCVax®-L for GBM Brain Cancer Is Ongoing

Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for solid...

Jun 01, 2015, 11:44 ET

NW Bio Announces Data to Date From DCVax®-Direct Phase I Trial

Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for solid...

May 27, 2015, 08:30 ET

NW Bio To Present Overview Of DCVax-Direct Phase I Trial In Chicago This Weekend

 Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for...

May 21, 2015, 10:56 ET

NW Bio To Present At New York Academy Of Sciences' Conference On Emerging Approaches To Immunotherapy

Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for cancer,...

May 06, 2015, 08:00 ET
View investor presentations 24/7 at www.virtualinvestorconferences.com.

NW Bio To Webcast, Live, at VirtualInvestorConferences.com On May 7

Company invites individual and institutional investors as well as advisors to attend real-time VirtualInvestorConferences.com  Northwest...

May 01, 2015, 10:54 ET

NW Bio Closes On $28.5 Million Second Tranche Of Woodford $40 Million Financing

 Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for...

Apr 20, 2015, 06:00 ET

NW Bio Featured In Presentations At the American Association for Cancer Research Annual Meeting

 Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for...